Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues.
作者信息
Inoue Jun, Ueno Yoshiyuki, Shimosegawa Tooru
机构信息
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
出版信息
Indian J Med Res. 2011 Jan;133(1):11-3.
Abstract
摘要
相似文献
1
Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues.
Indian J Med Res. 2011 Jan;133(1):11-3.
2
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4.
3
Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Aliment Pharmacol Ther. 2012 Jun;35(12):1482. doi: 10.1111/j.1365-2036.2012.05105.x.
4
Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:171-82. doi: 10.1111/j.1365-2036.2007.03481.x.
5
[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].
Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8. doi: 10.1016/s0213-005x(08)76517-0.
6
[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5.
7
[Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S22-5.
8
The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil.
J Viral Hepat. 2015 Mar;22(3):328-34. doi: 10.1111/jvh.12298. Epub 2014 Aug 14.
9
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.
Antiviral Res. 2010 Dec;88(3):269-75. doi: 10.1016/j.antiviral.2010.09.012. Epub 2010 Sep 25.
10
[Entecavir].
Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:39-48. doi: 10.1016/s0213-005x(08)76518-2.
引用本文的文献
1
Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
World J Gastroenterol. 2018 Feb 28;24(8):917-928. doi: 10.3748/wjg.v24.i8.917.
2
Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection.
Hepat Mon. 2016 Apr 27;16(5):e30385. doi: 10.5812/hepatmon.30385. eCollection 2016 May.
3
Inhibition of hepatitis B virus gene expression & replication by crude destruxins from Metarhizium anisopliae var. dcjhyium.
Indian J Med Res. 2013 Dec;138(6):969-76.
本文引用的文献
1
Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis.
Indian J Med Res. 2011 Jan;133(1):50-6.
2
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
Gastroenterology. 2010 Oct;139(4):1218-29. doi: 10.1053/j.gastro.2010.06.042. Epub 2010 Jun 20.
3
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
J Clin Virol. 2010 Aug;48(4):270-4. doi: 10.1016/j.jcv.2010.05.010. Epub 2010 Jun 26.
4
Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8.
5
Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.
J Viral Hepat. 2011 Mar;18(3):206-15. doi: 10.1111/j.1365-2893.2010.01301.x.
6
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.
J Gastroenterol Hepatol. 2010 Apr;25(4):745-9. doi: 10.1111/j.1440-1746.2009.06118.x. Epub 2010 Jan 13.
7
Enhanced intracellular retention of a hepatitis B virus strain associated with fulminant hepatitis.
Virology. 2009 Dec 20;395(2):202-9. doi: 10.1016/j.virol.2009.09.028. Epub 2009 Oct 21.
8
Chronic hepatitis B: update 2009.
Hepatology. 2009 Sep;50(3):661-2. doi: 10.1002/hep.23190.
9
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
J Hepatol. 2009 Feb;50(2):227-42. doi: 10.1016/j.jhep.2008.10.001. Epub 2008 Oct 29.
10
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.
Hepatology. 2007 Feb;45(2):307-13. doi: 10.1002/hep.21534.
Zotero 插件